Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Emedgene optimizes the workflows involved in tertiary analysis for rare disease genomics and various germline research endeavors. It is specifically built to enhance the speed and reliability of interpreting, prioritizing, curating, and generating research reports for user-defined variants. By incorporating explainable AI (XAI) and automation, Emedgene boosts efficiency across diverse analysis workflows, including genomes, exomes, virtual panels, and targeted panels. The platform facilitates the integration of laboratory processes and NGS instruments with IT systems, streamlining and securing the entire workflow. With continuous advancements in science, technology, and demand, Emedgene empowers users to stay current by offering cutting-edge knowledge graph features, curation tools, and expert support throughout their research journey. Furthermore, it allows laboratories to increase their throughput without the need for additional personnel, thanks to XAI and automated processes. Ultimately, Emedgene enables the deployment of high-throughput workflows for whole genome sequencing (WGS), whole exome sequencing (WES), virtual panels, or targeted panels that seamlessly fit into the digital framework of any lab. This comprehensive approach ensures that researchers can focus on their discoveries while relying on robust technological support.
Description
Efficiently generating reports for NGS-based clinical tests necessitates a well-established and sophisticated platform that can automatically prioritize variants, interpret clinical data, and create comprehensive reports. Strand Omics serves as a rapid, HIPAA-compliant cloud platform that enhances our clinical diagnostics efforts, having been refined over four years through the analysis of more than 10,000 clinical reports and numerous peer-reviewed studies. This platform integrates advanced bioinformatics algorithms with curated databases, intuitive visualization tools, and robust reporting features. It is designed with specialized workflows tailored for both rare inherited conditions and somatic tumor profiling assays. Additionally, the system boasts a library of over 10,000 somatic variants that have been curated for their oncogenic potential, alongside 100 genes selected for their druggability across various cancer types, as well as 500 drugs that have been validated for efficacy against multiple cancers. Furthermore, its comprehensive approach ensures that healthcare professionals have access to critical data, ultimately facilitating informed decision-making in patient care.
API Access
Has API
Yes
API Access
Has API
No
Integrations
Illumina DRAGEN Secondary Analysis
No
Pricing Details
No price information available.
Free Trial
Yes
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
Yes
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
No
In Person
No
Vendor Details
Company Name
Illumina
Country
United States
Website
www.illumina.com/products/by-type/informatics-products/emedgene.html
Vendor Details
Company Name
Strand Life Sciences
Founded
2000
Country
India
Website
strandls.com/bioinformatics/
Product Features
Product Features
Scientific Data Management System (SDMS)
Analytics
No
Artificial Intelligence (AI)
No
Audit
No
Centralized Data Repository
No
Collaboration
No
Compliance
No
Data Security
No
ELN Integration
No
LIMS Integration
No
Workflows
No